Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.45 SEK | -1.96% | -1.21% | -13.96% |
Apr. 16 | Mendus AB Announces Board Changes | CI |
Mar. 27 | Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML | CI |
- Stock Market
- Equities
- IMMU Stock
- News Mendus AB
- MarketScreener Editorial Features